Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of MAP7 protein | affects expression | 20106945
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of MAP7 mRNA | increases expression | 15761015
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of MAP7 mRNA | increases expression | 17879257
|
D005047 |
Etoposide |
MAP7 protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
D005576 |
Forskolin |
Forskolin results in increased expression of MAP7 mRNA | increases expression | 16751804
|
D008727 |
Methotrexate |
MAP7 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D015741 |
Metribolone |
Metribolone results in increased expression of MAP7 mRNA | increases expression | 16751804
|
D016685 |
Mitomycin |
MAP7 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
D011374 |
Progesterone |
Progesterone results in increased expression of MAP7 mRNA | increases expression | 18070364
|
C009250 |
sevoflurane |
sevoflurane affects the expression of MAP7 mRNA | affects expression | 15967596
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.48 | 12039119 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.48 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.48 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.74 | 6695378 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.29 | 19183758 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.13 | 17286800 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.84 | 16206674 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
5.43 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.60 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.47 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.06 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
2.06 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.06 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.06 | 16175315 15562024 17614352 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.51 | 11589617 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.17 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.17 | 16217749 15073043 14691202 11135700 15553829 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.14 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.28 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.09 | 20419170 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.38 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.03 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.03 | 12039119 9562676 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.40 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.28 | 15213294 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.32 | 20191521 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.71 | 17187935 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.98 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.93 | 16134523 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.56 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.56 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
3.46 | 15073043 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.46 | 16904648 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.36 | 16518429 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.74 | 20471113 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.80 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
4.02 | 15147373 18180244 16135485 16200630 17606976 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.62 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.68 | 15869954 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.29 | 9562676 |
MESH:D007859 |
Learning Disorders |
|
sevoflurane |
4.99 | 19212262 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.91 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.97 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.54 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.55 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.93 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.16 | 19850784 16968895 16467208 17050201 20471514 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.32 | 17649720 12679006 12018890 16966277 17712046 19225113 19035177 17869043 9834237 16331271 19075265 15748426 16891316 15622746 16823087 11161223 16112521 16330433 11468182 17217047 19642359 15336539 15213294 17107899 12712474 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.55 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.79 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
11.26 | 2125692 18177683 15890375 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
11.26 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
11.26 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
11.26 | 15113037 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.38 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.38 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.48 | 15213294 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.29 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.54 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.54 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.54 | 20869020 18816296 20135361 18520028 20064080 17053015 6695378 18569708 20464547 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
8.49 | 12854902 12556972 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
8.49 | 17352296 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
2.97 | 11408345 17203775 |
MESH:D008569 |
Memory Disorders |
|
sevoflurane |
4.95 | 19212262 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.32 | 16381670 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.52 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.22 | 19549372 19417148 15949261 14977855 11468182 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.94 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.23 | 16105982 16882451 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.16 | 16624393 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.24 | 11141357 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.22 | 10525206 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
5.10 | 12452020 19769630 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.10 | 16525653 17393432 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
9.18 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
9.18 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
9.18 | 15113037 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.35 | 19927285 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.61 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.61 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
2.61 | 17172428 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.48 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.93 | 17352296 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.91 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
11.12 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
11.12 | 14601052 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.44 | 10029692 19755658 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.52 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.40 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.40 | 20155912 2093021 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.23 | 9562676 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.22 | 19014326 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.20 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.24 | 12973940 20435036 11780464 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.24 | 17053015 |